282 related articles for article (PubMed ID: 8252039)
1. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
Weksberg R; Shen DR; Fei YL; Song QL; Squire J
Nat Genet; 1993 Oct; 5(2):143-50. PubMed ID: 8252039
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology of Beckwith-Wiedemann syndrome.
Weksberg R; Squire JA
Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
[TBL] [Abstract][Full Text] [Related]
3. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
Reeve AE
Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
[TBL] [Abstract][Full Text] [Related]
4. Analysis of CDKN1C in Beckwith Wiedemann syndrome.
Algar E; Brickell S; Deeble G; Amor D; Smith P
Hum Mutat; 2000; 15(6):497-508. PubMed ID: 10862080
[TBL] [Abstract][Full Text] [Related]
5. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype.
Murrell A; Heeson S; Cooper WN; Douglas E; Apostolidou S; Moore GE; Maher ER; Reik W
Hum Mol Genet; 2004 Jan; 13(2):247-55. PubMed ID: 14645199
[TBL] [Abstract][Full Text] [Related]
6. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.
Sun FL; Dean WL; Kelsey G; Allen ND; Reik W
Nature; 1997 Oct; 389(6653):809-15. PubMed ID: 9349812
[TBL] [Abstract][Full Text] [Related]
8. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
[TBL] [Abstract][Full Text] [Related]
9. Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor.
Riccio A; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Ferrero GB; Silengo MC; Russo S; Larizza L; Cerrato F
Endocr Dev; 2009; 14():1-9. PubMed ID: 19293570
[TBL] [Abstract][Full Text] [Related]
10. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome.
Ohlsson R; Nyström A; Pfeifer-Ohlsson S; Töhönen V; Hedborg F; Schofield P; Flam F; Ekström TJ
Nat Genet; 1993 May; 4(1):94-7. PubMed ID: 8513333
[TBL] [Abstract][Full Text] [Related]
11. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
[TBL] [Abstract][Full Text] [Related]
12. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome.
Hedborg F; Holmgren L; Sandstedt B; Ohlsson R
Am J Pathol; 1994 Oct; 145(4):802-17. PubMed ID: 7943172
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
Cooper WN; Luharia A; Evans GA; Raza H; Haire AC; Grundy R; Bowdin SC; Riccio A; Sebastio G; Bliek J; Schofield PN; Reik W; Macdonald F; Maher ER
Eur J Hum Genet; 2005 Sep; 13(9):1025-32. PubMed ID: 15999116
[TBL] [Abstract][Full Text] [Related]
14. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor.
Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Lausch E; Reutzel D; Fees S; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
Nat Genet; 2005 Aug; 37(8):785-6; author reply 786-7. PubMed ID: 16049499
[No Abstract] [Full Text] [Related]
15. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
Wu HK; Squire JA; Catzavelos CG; Weksberg R
Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
Wu HK; Weksberg R; Minden MD; Squire JA
Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
[TBL] [Abstract][Full Text] [Related]
17. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
18. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.
Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T
Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting.
Lee MP; DeBaun MR; Mitsuya K; Galonek HL; Brandenburg S; Oshimura M; Feinberg AP
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5203-8. PubMed ID: 10220444
[TBL] [Abstract][Full Text] [Related]
20. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.
Sperandeo MP; Ungaro P; Vernucci M; Pedone PV; Cerrato F; Perone L; Casola S; Cubellis MV; Bruni CB; Andria G; Sebastio G; Riccio A
Am J Hum Genet; 2000 Mar; 66(3):841-7. PubMed ID: 10712200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
